Recreational cannabis laws and opioid-related emergency department visit rates.

Recreational cannabis laws and opioid-related emergency department visit rates.
复制标题

DOI:
10.1002/hec.4377
复制
发表时间:
2021-09
期刊:
影响因子:
2.1
通讯作者:
Wen H
Wen H
中科院分区:
医学3区
文献类型:
--
作者:
Drake C;Wen J;Hinde J;Wen H

文献摘要

参考文献

被引文献

相似文献

在新冠肺炎大流行期间,美国的阿片类药物流行加速。截至2021年,大约三分之一的美国人现在生活在一个实行娱乐性大麻法律(RCL)的州。最近的证据表明,RCL可能是解决阿片类药物流行的一种减少危害的工具。个人可以使用大麻来止痛,以及缓解阿片类药物戒断症状,尽管它不直接治疗阿片类药物使用障碍。因此,尚不清楚RCL是否是减少与阿片类药物相关的不良健康后果的有效政策工具。在这项研究中,我们检查了RCL对阿片类药物相关不良健康结局的影响:阿片类药物相关急诊科就诊率。我们使用29个州从2011年到2017年的近全面的急救部门数据来估计事件研究模型。我们发现,RCL在实施后的两个季度内将与阿片类药物相关的急诊率降低了约7.6%。这些影响是由25-44岁的男性和成年人推动的。这些影响在六个月后就会消失。我们的估计表明,RCL没有增加与阿片类药物相关的急诊科就诊次数。我们的结论是,虽然大麻自由化可能在遏制阿片类药物流行方面提供一些帮助,但它可能不是灵丹妙药。
The opioid epidemic in the United States has accelerated during the COVID-19 pandemic. As of 2021, roughly a third of Americans now live in a state with a recreational cannabis law (RCL). Recent evidence indicates RCLs could be a harm reduction tool to address the opioid epidemic. Individuals may use cannabis to manage pain, as well as to relieve opioid withdrawal symptoms, though it does not directly treat opioid use disorder. It is thus unclear whether RCLs are an effective policy tool to reduce adverse opioid-related health outcomes. In this study, we examine the impact of RCLs on a key opioid-related adverse health outcome: opioid-related emergency department visit rates. We estimate event study models using nearly comprehensive emergency department data from 29 states from 2011 through 2017. We find that RCLs reduce opioid-related emergency department visit rates by roughly 7.6% for two quarters after implementation. These effects are driven by men and adults aged 25–44. These effects dissipate after six months. Our estimates indicate RCLs did not increase opioid-related emergency department visits. We conclude that, while cannabis liberalization may offer some help in curbing the opioid epidemic, it is likely not a panacea.
DOI: 10.1016/j.jhealeco.2017.12.007
发表时间: 2018-03
影响因子: 3.5
作者:
Powell D;Pacula RL;Jacobson M
通讯作者: Jacobson M
DOI: 10.1016/j.drugalcdep.2018.09.016
发表时间: 2019-01-01
影响因子: 4.2
作者:
Shi, Yuyan;Liang, Di;Grant, Igor
通讯作者: Grant, Igor
DOI: 10.1111/add.14031
发表时间: 2018-03
期刊: Addiction (Abingdon, England)
影响因子: --
作者:
Kerr WC;Lui C;Ye Y
通讯作者: Ye Y
DOI: 10.1002/hec.4237
发表时间: 2021-05
期刊: Health economics
影响因子: 2.1
作者:
Wen J;Wen H;Butler JS;Talbert JC
通讯作者: Talbert JC
DOI: 10.1073/pnas.1903434116
发表时间: 2019-06-25
影响因子: 11.1
作者:
Shover, Chelsea L.;Davis, Corey S.;Humphreys, Keith
通讯作者: Humphreys, Keith